Picture of BlinkLab logo

BB1 BlinkLab Share Price

0.000.00%
au flag iconLast trade - 00:00
TechnologySpeculativeMicro CapMomentum Trap

Momentum

Relative Strength (%)
1m-9.14%
3m-18.64%
6m+35.17%
1yr-10.71%
Volume Change (%)
10d/3m+6.2%
Price vs... (%)
52w High-26.56%
50d MA-5%
200d MA+15.89%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-80.83%
Return on Equity-130.35%
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202530th Jun 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of BlinkLab EPS forecast chart

Profile Summary

BlinkLab Limited is an Australia-based company focused on the development and commercialization of smartphone-neurobehavioral testing, to aid in the diagnosis of ASD, ADHD, schizophrenia and other neurodevelopmental conditions. The Company’s tests include eyeblink conditioning (EBC), prepulse inhibition of acoustic startle (PPI) and habituation of eye blink response, which serve as biomarkers for neurological and psychiatric disorders (BlinkLab Tests). The BlinkLab Device (BlinkLab Dx) consists of BlinkLab App, a mobile application for patients, caregivers and/or parents, effectively a front-end tool that helps collect test subjects’ information and responses to the BlinkLab Tests in real time (BlinkLab App), and BlinkLab Portal, which includes a fully built secure database and content management system (CMS) as well as experimenter’s portal that allows for full customization of the neurometric tests as well as data analysis, annotation and visualization tools (the BlinkLab Portal).

Directors

    Last Annual
    June 30th, 2024
    Last Interim
    December 31st, 2024
    Incorporated
    August 17th, 2021
    Public Since
    April 4th, 2024
    Sector
    Software & IT Services
    Industry
    Technology
    Exchange
    au flag iconAustralian Stock Exchange - SEATS
    Shares in Issue
    99,150,003
    Blurred out image of a map
    Address
    Level 5, 126-130 Phillip Street, SYDNEY, 2000
    Web
    https://www.blinklab.org/
    Phone
    Auditors
    Nexia Perth Audit Services Pty Ltd

    BB1 Share Price Performance

    Upcoming Events for BB1

    BlinkLab Ltd Annual Shareholders Meeting

    Similar to BB1

    Picture of 3P Learning logo

    3P Learning

    au flag iconAustralian Stock Exchange - SEATS

    Picture of 5G Networks logo

    5G Networks

    au flag iconAustralian Stock Exchange - SEATS

    Picture of 8Common logo

    8Common

    au flag iconAustralian Stock Exchange - SEATS

    Picture of ActivePort logo

    ActivePort

    au flag iconAustralian Stock Exchange - SEATS

    Picture of Adisyn logo

    Adisyn

    au flag iconAustralian Stock Exchange - SEATS

    FAQ